How One Man Survived Late-Stage Cancer and Gave Us Kurzgesagt

Kurzgesagt doesn’t usually tell personal stories, but this one is different, and it’s full of science anyway. Philipp Dettmer, the founder and head writer of Kurzgesagt, went through chemotherapy treatment for cancer in 2018. Years later, he is ready to tell the story, narrated by Steve Taylor and illustrated in the neon minimalist Kurzgesagt style. The drug is called Cisplatin. Like most chemotherapy drugs, it is very toxic and does quite bit of damage to a human body. Cancer therapies were developed by calibrating how much was required to kill cancer without killing the patient. That’s why chemotherapy is so debilitating, and only worth it at the end when you are deemed cancer-free.

WhatsApp
Facebook
Reddit
X
Telegram

Leave a Reply

 

Most Recent